Acquired pure red cell aplasia: Updated review of treatment

British Journal of Haematology

Volumn 142, Issue 4, 2008, Pages 505-514

  Sawada, Kenichi ^a   Fujishima, Naohito ^a   Hirokawa, Makoto ^a,b  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

Alemtuzumab; Corticosteroids; Cyclophosphamide; Cyclosporine A; Pure red cell aplasia; Rituximab

Indexed keywords

ALEMTUZUMAB; ANTIRETROVIRUS AGENT; AZATHIOPRINE; CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ABSENCE OF SIDE EFFECTS; ANEMIA; CLINICAL EVALUATION; COMBINATION CHEMOTHERAPY; COMPRESSION FRACTURE; DIAGNOSTIC TEST; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; LYMPHOCYTOPENIA; MAINTENANCE THERAPY; MONOTHERAPY; MYOPATHY; NEPHROTOXICITY; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PURE RED CELL ANEMIA; REMISSION; REVIEW; THYMECTOMY; THYMOMA; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTILYMPHOCYTE SERUM; CYCLOPHOSPHAMIDE; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RED-CELL APLASIA, PURE; THYMECTOMY;

EID: 47649129731     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07216.x     Document Type: Review

References (86)

1. Abkowitz, J.L., Powell, J.S., Nakamura, J.M., Kadin, M.E. Adamson, J.W. (1986) Pure red cell aplasia: response to therapy with anti-thymocyte globulin. American Journal of Hematology, 23, 363 371.
2. Ahern, M.J., Roberts-Thomson, P.J., Bradley, J., Story, C. Seshadri, P. (1990) Phenotypic and genotypic analysis of mononuclear cells from patients with Felty's syndrome. Annals of the Rheumatic Diseases, 49, 103 106.
3. Bassan, R., lntrona, M., Rambaldi, A., Viero, P., Chisesi, T., Mantovani, A. Barbui, T. (1986) Large granular lymphocyte/natural killer cell proliferative disease: clinical and laboratory heterogeneity. Scandinavian Journal of Haematology, 37, 91 96.
4. Batlle, M., Ribera, J.M., Oriol, A., Plensa, E., Millá, F. Feliu, E. (2002) Successful response to rituximab in a patient with pure red cell aplasia complicating chronic lymphocytic leukaemia. British Journal of Haematology, 118, 1192 1193.
5. Battiwalla, M., Melenhorst, J., Saunthararajah, Y., Nakamura, R., Molldrem, J., Young, N.S. Barrett, A.J. (2003) HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders. British Journal of Haematology, 123, 449 453.
6. Bladford, L.D. (2004) CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics, 5, 559 569.
7. Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., Varet, B. Mayeux, P. (2002) Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. The New England Journal of Medicine, 346, 469 475.
8. Cattran, D.C., Greenwood, C., Ritchie, S., Bernstein, K., Churchill, D.N., Clark, W.F., Morrin, P.A. Lavoie, S. (1995) A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney International, 47, 1130 1135.
9. Chan, W.C., Catovsky, D., Foucar, K. Montserrat, E. (2001) T-Cell Large Granular Lymphocyte Leukaemia: World Health Organization Classification of Tumours. Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, pp. 197 198.
10. Charles, R.J., Sabo, K.M., Kidd, P.G. Abkowitz, J.L. (1996) The pathophysiology of pure red cell aplasia: implications for therapy. Blood, 87, 4831 4838.
11. Clark, A.D., Dessypris, E.N. Krantz, S.B. (1984) Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood, 63, 277 286.
12. Csuka, M., Carrera, G.F. McCarty, D.J. (1986) Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study. The Journal of the American Medical Association, 255, 2315 2319.
13. Dessypris, E.N. (1988) Pure Red Cell Aplasia. The Johns Hopkins University Press, Baltimore and London.
14. Dessypris, E.N. Lipton, J.M. (2004) Red cell aplasia. In : Wintrobe's Clinical Hematology, 11th edn (eds by J.P. Greer, J. Foerster, J.N. Lukens, G.M. Rogers, M.D. Paraskevas B. Glader pp. 1421 1427. Lippincott Williams & Wilkins, Philadelphia.
15. Dhodapkar, M.V., Li, C.Y., Lust, J.A., Tefferi, A. Phyliky, R.L. (1994) Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood, 84, 1620 1627.
16. Dungarwalla, M., Marsh, J.C.W., Tooze, J.A., Lucas, G., Ouwehand, W., Pettengell, R., Dearden, C.E., Gordon Smith, E.C. Elebute, M.O. (2007) Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. Annals of hematology, 86, 191 197.
17. Firkin, F.C. Maher, D. (1988) Cytotoxic immunosuppressive drug treatment strategy in pure red cell aplasia. European Journal of Haematology, 41, 212 217.
18. Fisch, P., Handgretinger, R. Schaefer, H.E. (2000) Pure red cell aplasia. British Journal of Haematology, 111, 1010 1122.
19. Frickhofen, N., Abkowitz, J.L., Safford, M., Berry, J.M., Antunez-de-Mayolo, J., Astrow, A., Cohen, R., Halperin, I., King, L., Mintzer, D., Cohen, B. Young, N.S. (1990) Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Annals of Internal Medicine, 113, 926 933.
20. Garcia Vela, J.A., Monteserin, M.C., Oña, F., Barea, L.M., Lastra, A. Pérez, V. (1993) Cyclosporine A used as a single drug in the treatment of pure red cell aplasia associated with thymoma. American Journal of Hematology, 42, 238 239.
21. Gerli, R., Paganelli, R., Cossarizza, A., Muscat, C., Piccolo, G., Barbieri, D., Mariotti, S., Monti, D., Bistoni, O., Raiola, E., Venanzi, F.M., Bertotto, A. Franceschi, C. (1999) Long-term immunologic effects of thymectomy in patients with myasthenia gravis. Journal of Allergy and Clinical Immunology, 103, 865 872.
22. Ghazal, H. (2002) Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. Blood, 99, 1092 1094.
23. Go, R.S., Li, C.Y., Tefferi, A. Phyliky, R.L. (2001) Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood, 98, 483 485.
24. Go, R.S., Lust, J.A. Phyliky, R.L. (2003) Aplastic anemia and pure red cell aplasia associated with large granular lymphocyte leukemia. Seminars in Hematology, 40, 196 200.
25. Gonzales-Chambers, R., Przepiorka, D., Winkelstein, A., Agarwal, A., Starz, T.W., Kline, W.E. Hawk, H. (1992) Lymphocyte subsets associated with T cell receptor P-chain gene rearrangement in patients with rheumatoid arthritis and neutropenia. Arthritis & Rheumatism, 35, 516 520.
26. Gupta, N., Kavuru, S., Patel, D., Janson, D., Driscoll, N., Ahmed, S. Rai, K.R. (2002) Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia. Leukemia, 16, 2092 2095.
27. Hale, G. (2001) The CD52 antigen and development of the Campath antibodies. Cytotherapy, 3, 137 143.
28. Hamidou, M.A., Sadr, F.B., Lamy, T., Raffi, F., Grolleau, J.Y. Barrier, J.H. (2000) Low-dose methotrexate for the treatment of patients with large granular lymphocyte leukemia associated with rheumatoid arthritis. American Journal of Medicine, 108, 730 732.
29. Hegde, U.P., Wilson, W.H., White, T. Cheson, B.D. (2002) Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia. Blood, 100, 2260 2262.
30. Herbert, K.E., Prince, H.M. Westerman, D.A. (2003) Pure red-cell aplasia due to parvovirus B19 infection in a patient treated with alemtuzumab. Blood, 101, 1654.
31. Hirokawa, M., Sawada, K., Fujishima, N., Nakao, S., Urabe, A., Dan, K., Fujisawa, S., Yonemura, Y., Kawano, F., Omine, M., Ozawa, K. for the PRCA Collaborative Study Group. (2008) Long-Term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan for the PRCA collaborative study group. Haematologica, 93, 27 33.
32. Hoffacker, V., Schultz, A., Tiesinga, J.J., Gold, R., Schalke, B., Nix, W., Kiefer, R., Muller-Hermelink, H.K. Marx, A. (2000) Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood, 96, 3872 3879.
33. Hoffman, G.S., Kerr, G.S., Leavitt, R.Y., Hallahan, C.W., Lebovics, R.S., Travis, W.D., Rottem, M. Fauci, A.S. (1992) Wegener granulomatosis: an analysis of 158 patients. Annals of Internal Medicine, 116, 488 498.
34. Isobe, Y., Sugimoto, K., Shiraki, Y., Nishitani, M., Koike, K. Oshimi, K. (2004) Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy. American Journal of Hematology, 77, 370 373.
35. Kaznelson, P. (1922) Zur Entstehung der Blutplättchen. Verhandlungen der Deutschen Gesellschaft Fur Innere Medizin, 34, 557 558.
36. Keating, M.J., Flinn, I., Jain, V., Binet, J.L., Hillmen, P., Byrd, J., Albitar, M., Brettman, L., Santabarbara, P., Wacker, B. Rai, K.R. (2002) Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. Blood, 99, 3554 3561.
37. Krantz, S.B. Kao, V. (1967) Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei. Proceedings of the National Academy of Sciences of the United States of America, 58, 493 500.
38. Lacy, M.Q., Kurtin, P.J. Tefferi, A. (1996) Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood, 87, 3000 3006.
39. Lamy, T. Loughran, T.P. (1998) Large granular lymphocyte leukemia. Cancer Control, 5, 25 33.
40. Lamy, T. Loughran, Jr., T.P. (2003) Clinical features of large granular lymphocyte leukemia. Seminars in Hematology, 40, 185 195.
41. Loughran, Jr., T.P. (1993) Clonal diseases of large granular lymphocytes. Blood, 82, 1 14.
42. Loughran, Jr., T.P. Starkebaum, G. (1987) Large granular lymphocyte leukemia: report of 38 cases and review of the literature. Medicine (Baltimore), 66, 397 405.
43. Loughran, Jr., T.P., Draves, K.E., Starkebaum, G., Kidd, P. Clark, C.A. (1987) Induction of NK activity in large granular lymphocyte leukemia: activation with anti-CD3 monoclonal antibody and interleukin 2. Blood, 69, 72 78.
44. Loughran, Jr., T.P., Kidd, P.G. Starkebaum, G. (1994) Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood, 84, 2164 2170.
45. Mamiya, S., Itoh, T. Miura, A.B. (1997) Acquired pure red cell aplasia in Japan. European Journal of Haematology, 59, 199 205.
46. Marmont, A.M. (1991) Therapy of pure red cell aplasia. Seninars in Hematology, 28, 285 297.
47. Marmont, A., Peschle, C., Sanguineti, M. Condorelli, M. (1975) Pure red cell aplasia (PRCA): response of three patients of cyclophosphamide and/or antilymphocyte globulin (ALG) and demonstration of two types of serum IgG inhibitors to erythropoiesis. Blood, 45, 247 261.
48. Means, Jr., R.T., Dessypris, E.N. Krantz, S.B. (1991) Treatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical response. British Journal of Haematology, 78, 114 119.
49. Mylonakis, E., Dickinson, B.P., Mileno, M.D., Flanigan, T., Schiffman, F.J., Mega, A. Rich, J.D. (1999) Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy. American Journal of Hematology, 60, 164 166.
50. Narra, K., Borghaei, H., Al-Saleem, T., Höglund, M. Smith, M.R. (2006) Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature. Leukemia Research, 30, 109 114.
51. Oshimi, K. (1988) Granular lymphocyte proliferative disorders: report of 12 cases and review of the literature. Leukemia, 2, 617 627.
52. Oshimi, K., Yamada, O., Kaneko, T., Nishinarita, S., Iizuka, Y., Urabe, A., Inamori, T., Asano, S., Takahashi, S., Hattori, M., Naohara, T., Ohira, Y., Togawa, A., Masuda, Y., Okubo, Y., Furusawa, S., Sakamoto, S., Omine, M., Mori, M., Tatsumi, E. Mizoguchi, H. (1993) Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia, 7, 782 788.
53. Osuji, N., Matutes, E., Tjonnfjord, G., Grech, H., Del Giudice, I., Wotherspoon, A., Swansbury, J.G. Catovsky, D. (2006) T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature. Cancer, 107, 570 578.
54. Pantelidou, D., Tsatalas, C., Margaritis, D., Kaloutsi, V., Spanoudakis, E. Bourikas, G. (2004) Anti-CD20 monoclonal antibody rituximab for the treatment of B-cell chronic lymphocytic leukemia-associated pure red cell aplasia. The Hematology Journal, 5, 546 547.
55. Quartier, P., Brethon, B., Philippet, P., Landman-Parker, J., Le Deist, F. Fischer, A. (2001) Treatment of childhood autoimmune haemolytic anaemia with rituximab. Lancet, 358, 1511 1513.
56. Radis, C.D., Kahl, L.E., Baker, G.L., Wasko, M.C., Cash, J.M., Gallatin, A., Stolzer, B.L., Agarwal, A.K., Medsger, Jr., T.A. Kwoh, C.K. (1995) Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study. Arthritis Rheumatism, 38, 1120 1127.
57. Raghavachar, A. (1990) Pure red cell aplasia: review of treatment and proposal for a treatment strategy. Blut, 61, 47 51.
58. Ramratnam, B., Gollerkeri, A., Schiffman, F.J., Rintels, P. Flanigan, T.P. (1995) Management of persistent B 19 parvovirus infection in AIDS. British Journal of Haematology, 91, 90 92.
59. Reinhold-Keller, E., Beuge, N., Latza, U., de Groot, K., Rudert, H., Nolle, B., Heller, M. Gross, W.L. (2000) An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheumatism, 43, 1021 1032.
60. Rossert, J., Casadevall, N. Eckardt, K.U. (2004) Anti-erythropoietin antibodies and pure red cell aplasia. Journal of the American Society of Nephrology, 15, 398 406.
61. Rossert, J., Macdougall, I. Casadevall, N. (2005) Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: multiple options. Nephrology, dialysis, transplantation, 20 (Suppl 4 iv23 iv26.
62. Ru, X. Liebman, H.A. (2003) Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H). British Journal of Haematology, 123, 278 281.
63. Sawada, K., Hirokawa, M., Fujishima, N., Teramura, M., Bessho, M., Dan, K., Tsurumi, H., Nakao, S., Urabe, A., Omine, M., Ozawa, K. PRCA Collaborative Study Group. (2007) Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica, 92, 1021 1028.
64. Semenzato, G., Pandolfi, F., Chisesi, T., De Rossi, G., Pizzolo, G., Zambello, R., Trentin, L., Agostini, C., Dini, E., Vespignani, M., Cafaro, A., Pasqualetti, D., Giubellino, M.C., Migone, N. Foà, R. (1987) The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer, 60, 2971 2978.
65. Semenzato, G., Zambello, R., Starkebaum, G., Oshimi, K. Loughran, Jr., T.P. (1997) The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood, 89, 256 260.
66. Sharma, V.R., Fleming, D.R. Slone, S.P. (2000) Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood, 96, 1184 1186.
67. Smith, M.R. (2003) Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance. Oncogene, 22, 7359 7368.
68. Song, K.W., Mollee, P., Patterson, B., Brien, W. Crump, M. (2002) Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma. British Journal of Haematology, 119, 125 127.
69. Sood, R., Stewart, C.C., Aplan, P.D., Murai, H., Ward, P., Barcos, M. Baer, M.R. (1998) Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood, 91, 3372 3378.
70. Stasi, R., Pagano, A., Stipa, E. Amadori, S. (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood, 98, 952 957.
71. Stead, R.B., Lambert, J., Wessels, D., Iwashita, J.S., Leuther, K.K., Woodburn, K.W., Schatz, P.J., Okamoto, D.M., Naso, R. Duliege, A.M. (2006) Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers. Blood, 108, 1830 1834.
72. Suzuki, S., Nogawa, S., Tanaka, K., Koto, A., Fukuuchi, Y. Kuwana, M. (2003) Initial predictors of development of pure red cell aplasia in myasthenia gravis after thymectory. Clinical Neurology and Neurosurgery, 106, 16 18.
73. Teramura, M., Kimura, A., Iwase, S., Yonemura, Y., Nakao, S., Urabe, A., Omine, M. Mizoguchi, H. (2007) Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporine with or without G-CSF in adults: a multicenter randomized study in Japan. Blood, 110, 1756 1761.
74. Thompson, C.A. Steensma, D.P. (2006) Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience. British Journal of Haematology, 135, 405 407.
75. Totterman, T.H., Nisell, J., Killander, A., Gahrton, G. Lonqvist, B. (1984) Successful treatment of pure red cell aplasia with cyclosporine. Lancet, 2, 694.
76. Tötterman, T.H., Höglund, M., Bengtsson, M., Simonsson, B., Almqvist, D. Killander, A. (1989) Treatment of pure red-cell aplasia and aplastic anaemia with ciclosporin: long-term clinical effects. European Journal of Haematology, 42, 126 133.
77. Verhelst, D., Rossert, J., Casadevall, N., Kruger, A., Eckardt, K.U. Macdougall, I.C. (2004) Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study. Lancet, 363, 1768 1771.
78. Weber, G., Gross, J., Kromminga, A., Loew, H.H. Eckardt, K.U. (2002) Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins. Journal of the American Society of Nephrology, 13, 2381 2383.
79. Willis, F., Marsh, J.C.W., Bevan, D.H., Killick, S.B., Lucas, G., Griffiths, R., Ouwehand, W., Hale, G., waldmann, H. Gordon-Smith, E.C. (2001) The effect of treatment with Campath-1H in patients with autoimmune cytopenias. British Journal Haematology, 114, 891 898.
80. Wong, T.Y., Chan, P.K., Leung, C.B., Szeto, C.C., Tam, J.S. Li, P.K. (1999) Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. American Journal of Kidney Diseases, 34, 1132 1136.
81. Woodburn, K.W., Fan, Q., Winslow, S., Chen, M.J., Mortensen, R.B., Casadevall, N., Stead, R.B. Schatz, P.J. (2007) Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model. Experimental Hematology, 35, 1201 1208.
82. Yamada, O., Mizogucji, H. Oshimi, K. (1997) Cyclophosphamide therapy for pure red cell aplasia associated with granular lymphocyte-proliferative disorders. British Journal of Haematology, 97, 392 399.
83. Young, N.S., Calado, R.T. Scheinberg, P. (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood, 108, 2509 2519.
84. Zaentz, S.D., Krantz, S.B. Brown, E.B. (1976) Studies on pure red cell aplasia. Maintenance therapy with immunosuppressive drugs. British Journal of Haematology, 32, 47 54.
85. Zecca, M., Stefano, P., Nobili, B. Locatelli, F. (2001) Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. Blood, 97, 3995 3997.
86. Zeok, J.V., Todd, E.P., Dillon, M., DeSimone, P. Utley, J.R. (1979) The role of thymectomy in red cell aplasia. The Annals of Thoracic Surgery, 28, 257 260.